Lumbar disc herniation (LDH) is a frequent low back condition. It's one of the most frequent disorders that causes low back and/or leg discomfort in people. A herniated disc occurs when disc material (nucleus pulposus or annulus fibrosis) is displaced outside the intervertebral disk's region. This herniation cycle begins with failure in the innermost annulus rings and moves radially outward. Damage to the annulus of the disc is commonly related with totally flexing the spine over an extended period of time. Almost 80% of the population will have low back pain (LBP) at least once in their lives. LBP costs the United States more than USD 100 billion per year due to its high prevalence and major contribution to disability. The most common cause of LBP is intervertebral degeneration, which results in degenerative disc disease and lumbar disc herniation (LDH). Lumbar disc herniation, which most usually affects the L4-L5 and L5-S1 levels, is a major cause of low back pain and radicular leg discomfort.

Data Bridge Market Research analyses that the lumbar disc herniation treatment market was valued at USD 2.568 million in 2021 and is expected to reach USD 4.16 million by 2029, registering a CAGR of 6.20% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Get the sample copy of Report @- https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-lumbar-disc-herniation-treatment-market

The lumbar disc herniation treatment market is segmented on the basis of type, location type, treatment, diagnosis, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Location Type

  • Axillary
  • Foraminal
  • Posterolateral
  • Central Prolapse

Diagnosis

  • Nerve Tests
  • Electromyography (EMG)
  • Nerve conduction study
  • Imaging Tests
  • Magnetic resonance imaging (MRI)
  • Myelogram
  • Computerized tomography (CT) scan
  • X-rays
  • Others

Treatment

  • Medication
  • Non-steroidal anti-inflammatory drugs (NSAIDs)
  • Opioids
  • Muscle relaxers
  • Local corticosteroid injections (CSI)
  • Surgery
  • Far lateral microdiskectomy
  • Laminotomy and discectomy
  • Physical Therapy
  • Others

Type

  • Chronic
  • Acute

Dosage Form

Route of Administration

  • Parenteral
  • Oral
  • Others

End-Users

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Highlight of Table of Content:

·        Chapter 1: Market overview

·        Chapter 2: Global Lumbar Disc Herniation Treatment Market analysis

·        Chapter 3: Regional analysis of the Global Lumbar Disc Herniation Treatment Market

·        Chapter 4: Market segmentation based on types and applications

·        Chapter 5: Revenue analysis based on types and applications

·        Chapter 6: Market share

·        Chapter 7: Competitive Landscape

·        Chapter 8: Drivers, Restraints, Challenges, and Opportunities

·        Chapter 9: Gross Margin and Price Analysis

Get Details TOC of this report@- https://www.databridgemarketresearch.com/toc/?dbmr=global-lumbar-disc-herniation-treatment-market

Some of the major players operating in the lumbar disc herniation treatment market are:

  • Pfizer Inc. (US)
  • GlaxoSmithKline plc (UK)
  • Novartis AG (Switzerland)
  • Mylan N.V. (US)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Sanofi (France)
  • Boehringer Ingelheim International GmbH. (Germany)
  • AstraZeneca (UK)
  • Johnson & Johnson Private Limited (US)
  • Merck & Co., Inc. (US)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Aurobindo Pharma (India)
  • Zydus Cadila (India)
  • NuVasive, Inc. (US)
  • Globus Medical (US)
  • Zimmer Biomet (US)
  • Medtronic (Ireland)

Profound Questions Answered in this Report:

·       What is the growth rate of various stages in the value chain of the industry?

·       Which region has the highest growth rate and size of the emerging market by value in 2022?

·       Who are the competitive players in Globa Lumbar Disc Herniation Treatment Market?

·       Which region has the largest share and degree of competition in the industry?

·       What is the CAGR of the market during the forecast period 2022 to 2029?

·       Which region is expected to hold the highest market share for the market?

·       What is the main driver of the Global Lumbar Disc Herniation Treatment Market?

·       What is sales volume, revenue, and price analysis of top players of the market?

·       What are the market opportunities and threats faced by the vendors in the industry?

·       What has been the impact of COVID-19 on the Global Lumbar Disc Herniation Treatment Market?

 

Asceses Full report@- https://www.databridgemarketresearch.com/reports/global-lumbar-disc-herniation-treatment-market

Browser Related Report@-

Trachoma Market

immune Thrombocytopenia Market

Sertraline Market

Purine Analogues Drugs Market

Orthodontic Bands Market

Biologic Imaging Reagents Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com